Wavelength Pharmaceuticals

filter Subject

All (2)

01 CISATRACURIUM BESYLATE PROCESS B (1)

02 SITAGLIPTIN PHOSPHATE MONOHYDRATE (1)

filter Holder

All (2)

01 WAVELENGTH ENTERPRISES LTD (2)

filter Country

All (2)

01 Blank (2)

filter Status

All (2)

01 Active (2)

filter GDUFA DMF Review

All (2)

01 Complete (1)

02 Blank (1)

List of Drug Master Files (DMF) of Active Pharmaceutical Ingredients (APIs) submissions by Wavelength Pharmaceuticals to the U.S. FDA. Original Data : FDA Website

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

2 Interviews #SpeakPharma

32 News

APIs // Active Pharmaceutical Ingredients

2 APIs

2 USDMF

DEVELOPMENTS

INSPECTIONS & REGISTRATIONS

1 EDQM

2 GDUFA

Wavelength Pharmaceuticals

CISATRACURIUM BESYLATE PROCESS B

WAVELENGTH ENTERPRISE...

Active

39123

Complete

2024-03-19

2024-01-22

2024-01-29

II

SITAGLIPTIN PHOSPHATE MONOHYDRATE

WAVELENGTH ENTERPRISE...

Active

39377

N/A

2024-02-02

II